Mississauga, ON -- (SBWIRE) -- 12/09/2019 -- AllPennyStocks.com Media, Inc. (https://www.AllPennyStocks.com/) announces its latest article titled "Voyageur Stands Alone to Disrupt the $7 Billion Contrast Media Market."
Companies mentioned in this article include Voyageur Pharmaceuticals (TSX-Venture:VM).
Article Excerpt:
If your body hurts in any way, there is a good chance that contrast media is going to have a role in figuring out what is wrong. Contrast media is integral to common tests like X-rays, MRIs, CT scans and ultrasounds used every day the world over to enhance visibility of internal body parts to help doctors make educated decisions regarding a broad array of maladies.
Aging populations and increased frequency of chronic conditions are propelling growth in the contrast media industry that Research and Markets forecasts to hold mid-single digits annual growth to reach $6.9 billion in the next five years. Some of the indications where these tests are utilized daily include cardiovascular disorders, cancer, gastrointestinal problems, musculoskeletal issues, neurological conditions and nephrological diseases.
The full version of this article can be found at:
https://www.allpennystocks.com/specialreportsca/1257/voyageur-stands-alone-to-disrupt-the-7-billion-contrast-media-market
About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
Contact:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has been compensated five thousand dollars by a third-party, Frontier Consulting LLC. for its efforts in presenting the VM profile on its web site and distributing it to its database of subscribers as well as other services. For a complete disclaimer, investors are encouraged to click here: https://www.allpennystocks.com/SpotLight/49/Voyageur-Pharmaceuticals-Ltd.htm.